You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 14, 2024

CLINICAL TRIALS PROFILE FOR LURASIDONE HYDROCHLORIDE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Lurasidone Hydrochloride

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00044005 ↗	Safety and Tolerability Study of Drug to Treat Schizophrenia	Completed	Sunovion	Phase 2	2002-09-01	The purpose of this study is to evaluate the long-term safety of SM-13496 in patients with schizophrenia.
NCT00088621 ↗	A Study to Test the Safety and Tolerability of a New Medication in the Treatment of Schizophrenia	Completed	Sunovion	Phase 2	2004-07-01	A 1-year outpatient study to test the safety and tolerability of a new medication in the treatment of schizophrenia
NCT00088634 ↗	A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia	Completed	Sunovion	Phase 2	2004-05-01	A 6-week in-patient and out-patient study to test the effectiveness and safety of a new medication in the treatment of schizophrenia
NCT00549666 ↗	A Randomized, Placebo-Controlled, Two-Period, Crossover Study to Evaluate the Effect of Lurasidone HCl on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects	Completed	Sunovion	Phase 1	2007-08-01	A Phase 1, drug, drug, interaction study between Lurasidone HCl and Ortho-tri cyclen
NCT00549718 ↗	Lurasidone HCl: A Phase 3 Study of Patients With Acute Schizophrenia	Completed	Sunovion	Phase 3	2007-10-01	Lurasidone HCl is a compound being developed for the treatment of schizophrenia. This clinical study is designed to test the hypothesis that lurasidone is more efficacious than placebo. The study will also evaluate the safety and tolerability of lurasidone as compared to placebo.
NCT00615433 ↗	Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia	Completed	Sunovion	Phase 3	2008-01-01	Lurasidone HCl is a compound developed for the treatment of schizophrenia. This clinical study is designed to test the hypothesis that lurasidone is more efficacious than placebo. The study will also evaluate the safety and tolerability of lurasidone as compared to placebo.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Lurasidone Hydrochloride

Condition Name

Chart
Table

Condition Name for Lurasidone Hydrochloride
Intervention	Trials
Schizophrenia	39
Bipolar Depression	16
Bipolar Disorder	9
Bipolar I Disorder	6
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Lurasidone Hydrochloride
Intervention	Trials
Schizophrenia	42
Bipolar Disorder	25
Depression	22
Depressive Disorder	20
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Lurasidone Hydrochloride

Trials by Country

Map
Table

Trials by Country for Lurasidone Hydrochloride
Location	Trials
United States	452
India	61
China	30
Japan	22
Ukraine	18
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Lurasidone Hydrochloride
Location	Trials
California	37
Texas	33
New York	31
Florida	29
Pennsylvania	23
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Lurasidone Hydrochloride

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Lurasidone Hydrochloride
Clinical Trial Phase	Trials
Phase 4	14
Phase 3	39
Phase 2/Phase 3	4
[disabled in preview]	19
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Lurasidone Hydrochloride
Clinical Trial Phase	Trials
Completed	59
Recruiting	9
Not yet recruiting	4
[disabled in preview]	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Lurasidone Hydrochloride

Sponsor Name

Chart
Table

Sponsor Name for Lurasidone Hydrochloride
Sponsor	Trials
Sunovion	41
Target Health Inc.	6
NeuroRx, Inc.	6
[disabled in preview]	15
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Lurasidone Hydrochloride
Sponsor	Trials
Industry	73
Other	43
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.